Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Core EBITDA Growth

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 190.99-84.21-1.87172.3626.79

What is the latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM ?

The latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM is 190.99 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025190.99
Mar2024-84.21
Mar2023-1.87
Mar2022172.36
Mar202126.79

How is Core EBITDA Growth of SAMRAT PHARMACHEM Trending?

Years Core EBITDA Growth % Change
Mar2025 190.99
Positive
Mar2024 -84.21
Negative
Mar2023 -1.87
Negative
Mar2022 172.36
543.37
Mar2021 26.79 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare Core EBITDA Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹73.7 Cr 11.1% 2.8% -37% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 5% -0.1% 3.3% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

11.1%

2.8%

-37%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses